SEL-203

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSEL-203
Drug Alias NameSEL-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor agonists
TargetsMetabotropic glutamate receptor
Therapy Area/IndicationsFragile X SyndromeCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRyvu Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRyvu Therapeutics Sa
Active IndicationsN/A
Inactive IndicationsFragile X SyndromeCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A